Abstract:Cinnabarinic acid (CA) is a high-value nitrogen-containing tricyclic phenoxazinone widely used in dyeing, chemical, and pharmaceutical industries. However, the efficient CA synthetic system for large-scale CA production has not been constructed until now. To achieve efficient CA biosynthesis, we constructed an in vitro enzymatic synthetic system and a whole-cell biocatalytic platform for CA biosynthesis in this study. Firstly, targeting the main limiting factor of the CA synthesis, we identified a superoxide dismutase SodAPrm capable of efficiently converting 3-hydroxyanthranilate to CA. Subsequently, the in vitro catalytic parameters of SodAPrm were optimized, after which (176.6±14.3) mg/L CA was efficiently synthesized. Then, based on the selected SodAPrm, an Escherichia coli whole-cell catalytic system BL-sodAPrmwas constructed for CA biosynthesis. Finally, a maximal titer of 312.3 mg/L CA was synthesized after optimization of the reaction conditions of whole-cell catalytic system BL-sodAPrm. In summary, this study lays a profoundly foundation for the biosynthesis and application of CA and its derivatives in the future.